Rx Drug Promotion Studies Target Biosimilar Disclosures, Unapproved Uses, Multiple Indications

 
• By Brenda Sandburg
  
Conceptual business illustration with the words direct-to-consumer advertising
FDA proposes three new studies of Rx drug promotion • Source: Shutterstock

More from Marketing & Advertising

More from Compliance